Letter/Comment
The latest advocacy letters and comments from the 黑料正能量 Association.
AHA comments on the CMS鈥 Request for Information on Essential Health Benefits (EHB).
AHA comments on the CMS' proposed Notice of Benefit and Payment Parameters for 2024.
AHA provides feedback to the Senate on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress鈥 continued efforts to transform health care through permanent telehealth reform.
AHA provides feedback on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress鈥 continued efforts to transform health care through permanent telehealth reform
AHA comments proposed revisions to the regulations governing the confidentiality of substance use disorder (SUD) records, commonly known as 42 CFR Part 2 (鈥淧art 2鈥).
January 27, 2023
Emeka Egwim, PharmD, RPh LCDR
U.S. Public Health Service Director
Office of Pharmacy Affairs
Health Resources and Services Administration 5600 Fishers Lane, 08W05A
Rockville, MD 20857
RE: HRSA 340B Drug Pricing Program; Administrative Dispute Resolution Proposed Rule, HHS Docket鈥
AHA Comments on AHRQ鈥檚 Request for Information on Creating a National Health Care System Action Alliance to Advance Patient Safety, Dec. 12, 2022
The AHA appreciates the opportunity to share our comments and asks that commissioners consider the following issues before making their final payment update recommendations.
AHA expresses concern about the potential impact of H.R. 3648, the Equal
Access to Green Cards for Legal Employment (EAGLE) Act of 2022
The 黑料正能量 Association (AHA) writes to provide feedback on the cybersecurity policy proposals released in Senator Mark R. Warner's report last month. Cybersecurity is, at its core, a necessary element of patient safety for hospitals and health systems.